Extracellular vesicles of ADSCs inhibit ischemic stroke-induced pyroptosis through Gbp3 regulation: A role for the NLRP3/GSDMD signaling pathway DOI
Jia Wang, Hao Tang, Jianan Tian

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113881 - 113881

Опубликована: Дек. 24, 2024

Язык: Английский

Insights into tumor-derived exosome inhibition in cancer therapy DOI
Ziwei Tang, Cheng Chen, Chen Zhou

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 285, С. 117278 - 117278

Опубликована: Янв. 13, 2025

Язык: Английский

Процитировано

3

Extracellular vesicles and microRNAs in cancer progression DOI
Nicola Salvatore Orefice, Gianluca Petrillo,

Claudia Pignataro

и другие.

Advances in clinical chemistry, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Unraveling the role of the P2X7 receptor in cancer radioresistance: Molecular insights and therapeutic implications DOI

Seyedeh Nasibeh Mousavikia,

Maryam Moghaddam Matin,

Mohammad Taghi Bahreyni Tossi

и другие.

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Год журнала: 2025, Номер 1872(3), С. 119910 - 119910

Опубликована: Янв. 29, 2025

Язык: Английский

Процитировано

1

Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs DOI Creative Commons

Guo Shu-hua,

Xiaozhi Xi

Biomarker Research, Год журнала: 2025, Номер 13(1)

Опубликована: Март 11, 2025

Abstract CAR-T cells are genetically modified T lymphocytes that express chimeric antigen receptors (CAR) on their surfaces. These enable to recognize specific antigens target cells, triggering a response leads targeted cytotoxicity. While therapy has effectively treated various blood cancers, it faces significant challenges in addressing solid tumors. include identifying precise tumor antigens, overcoming evasion, and enhancing the function of within microenvironment. Single domain antibody, versatile tools with low immunogenicity, high stability, strong affinity, show promise for improving efficacy against By these challenges, single antibody potential overcome limitations associated ScFv antibody-based therapies. This review highlights benefits utilizing therapy, particularly targeting explores development strategies could advance field.

Язык: Английский

Процитировано

0

Tumor-derived vesicles in immune modulation: focus on signaling pathways DOI Creative Commons
Fei Yin,

Yangfang He,

Yue Qiao

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Май 15, 2025

Tumor-derived extracellular vesicles (TDEVs) represent a heterogeneous population of (EVs), including exosomes, microvesicles, and apoptotic bodies, which are essential for tumor growth. EVs function as natural carriers bioactive molecules, lipids, proteins, nucleic acids, enabling them to influence regulate complex cellular interactions within the microenvironment (TME). The TDEVs mainly have immunosuppressive functions result inhibitory signals disrupting immune cell anti-tumor activity. They enhance progression evasion by inhibiting effector cells altering critical processes recruitment, polarization, functional suppression different signaling pathways. In this sense, modulate NF-κB pathway, promoting inflammation inducing evasion. Janus kinase (JAK)-signal transducer activator transcription (STAT) is required TDEV-mediated manifestation tumor-supporting features. phosphoinositide 3-kinase (PI3K)/protein B (Akt)/mammalian target rapamycin (mTOR) signaling, necessary metabolic reprogramming, orchestrated TDEV abrogate response drive cancer proliferation. Finally, exosomal cargo can NOD-, LRR-, pyrin domain-containing protein 3 (NLRP3) inflammasome, activating pro-inflammatory responses that development immunomodulation. review, we take deep dive into how affect key We also examine emerging therapeutic approaches aimed at EV-mediated pathways, offering promising avenues novel EV-based immunotherapy.

Язык: Английский

Процитировано

0

Therapeutic vaccine strategies in cancer: advances, challenges, and future directions DOI Creative Commons

Chiyuan Wang,

Pei Hao

Clinical Cancer Bulletin, Год журнала: 2025, Номер 4(1)

Опубликована: Май 26, 2025

Язык: Английский

Процитировано

0

In Vitro Assessment of Antiproliferative Properties of a Novel Benzoxazole-Conjugated Pyrrolotriazinone DOI Open Access
Burak Kuzu, Kemal Alp Nalcı

International Journal of Chemistry and Technology, Год журнала: 2025, Номер 9(1), С. 107 - 116

Опубликована: Июнь 4, 2025

In this study, a new class of antiproliferative agents was designed and synthesized against glioblastoma, the most lethal aggressive primary brain tumor. The structure by hybridizing benzoxazole pyrrolotriazinone, two important pharmacophore groups for antiproliferation. target compound in six-step procedure. benzoxazole-conjugated pyrrolotriazinone characterized FT-IR, 1H- 13C-NMR spectra. It found to have favorable drug similarity theoretical pharmacokinetic parameters according silico methods. effect on glioblastoma cell line U-87 MG evaluated, showing dose-dependent effectiveness. Furthermore, study investigates molecular docking novel with key glioblastoma-associated targets, revealing its potential as multi-target therapeutic agent. demonstrates strong binding affinity inhibitory VEGFR-2, VEGFR-1, PI3K, shows significant activity apoptotic pathways through Caspase-3 BCL-2. These results suggest disrupt tumor growth, angiogenesis, proliferation. Overall, hybrid promise treatment could represent step forward design candidates future.

Язык: Английский

Процитировано

0

Fascial Manual Medicine: A Continuous Evolution DOI Open Access
Bruno Bordoni, Allan R Escher

Cureus, Год журнала: 2024, Номер unknown

Опубликована: Окт. 14, 2024

From the perspective of fascial manual medicine (FMM), body should not be considered as a set compartments, but functional continuum, where most tissues (considering embryology) are fascia. The cells that make up fascia can use multiple strategies to communicate, with neighboring cells, tissue which they belong, and entire body, thanks biochemical (microscopy) electromagnetic (nanoscopy) possibilities. These capacities send receive information border or layer different seem absent. All techniques profess only ones work on patient's symptoms, dictating standardized procedure all patients undergo, represent clinical deviation. Likewise, thinking approach provide biomechanical stimuli single specific structure is conceptual error. This narrative review briefly reviews history fascial-related nomenclature how system currently considered, posing new reflections continuum could conceived by practitioners who apply FMM in clinic, such osteopaths, chiropractors, physiotherapists.

Язык: Английский

Процитировано

1

Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management DOI Creative Commons
Yanming Dong, Guo‐Qiang Bao

Open Life Sciences, Год журнала: 2024, Номер 19(1)

Опубликована: Янв. 1, 2024

Abstract This study aims to comprehensively investigate the role of coagulation factor II thrombin receptor (F2R) in breast cancer (BC) and evaluate its potential as a biomarker this context. Data on female BC were retrieved from TCGA database. Comparative analyses performed, including enrichment analysis, tumor immune microenvironment drug sensitivity testing, molecular docking, cell-based experiments, assess expression function F2R BC. Statistical graphical representations conducted using R software. The confirmed significant upregulation BC, which was associated with more favorable prognosis. Clinical correlation analysis revealed strong association between key clinical parameters, such estrogen progesterone status. Additionally, genes co-expressed significantly linked various biological processes, cell cycle regulation, oxidative phosphorylation, ribosomal function, extracellular matrix interactions. also showed associations modulators, particularly CD200 NRP1. Drug experiments consistently demonstrated positive correlations dasatinib. underscores valuable providing insights into mechanisms underlying tumorigenesis.

Язык: Английский

Процитировано

0

Extracellular vesicles of ADSCs inhibit ischemic stroke-induced pyroptosis through Gbp3 regulation: A role for the NLRP3/GSDMD signaling pathway DOI
Jia Wang, Hao Tang, Jianan Tian

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113881 - 113881

Опубликована: Дек. 24, 2024

Язык: Английский

Процитировано

0